O36.1125 Maternal care for Anti-A sensitization, second trimester, fetus 5

Name of the Condition

• Maternal care for Anti-A sensitization, second trimester, fetus 5
• ICD Code: O36.1125

Summary

This condition involves medical care and monitoring provided to a pregnant woman with anti-A antibodies during the second trimester for a multifetal pregnancy with five fetuses. The care focuses on managing the potential risks to the fetuses and ensuring maternal health, particularly addressing the risk of hemolytic disease of the fetus and newborn (HDFN).

Causes

Anti-A sensitization occurs when an individual with type O blood (lacking A antigens) is exposed to A-positive blood, triggering the production of anti-A antibodies. In pregnancy, this exposure may happen during a previous pregnancy with an A-positive fetus, blood transfusion, or events causing fetal-maternal blood mixing. These antibodies can cross the placenta and attack the red blood cells of an A-positive fetus.

Risk Factors

• Previous pregnancy with an A-positive fetus
• Blood transfusion with A-positive blood
• Abdominal trauma during pregnancy
• Invasive prenatal procedures (e.g., amniocentesis)
• Prior miscarriage or ectopic pregnancy involving an A-positive fetus

Symptoms

• Often asymptomatic in the mother
• Fetal anemia, jaundice, or hydrops fetalis in severe cases
• Elevated bilirubin levels in the newborn

Diagnosis

Diagnosis involves blood typing and antibody screening to detect anti-A antibodies. Fetal monitoring may include ultrasound, Doppler velocimetry, or amniocentesis to assess for anemia or hydrops. Serial antibody titers help track sensitization severity.

Treatment Options

• Close monitoring of maternal antibody levels and fetal well-being
• Intrauterine transfusions for severely anemic fetuses
• Early delivery planning if fetal compromise is detected
• Postnatal care for newborns at risk of HDFN

Prognosis and Follow-Up

Prognosis depends on the severity of fetal anemia and timely intervention. Regular follow-up includes monitoring fetal growth, amniotic fluid levels, and maternal antibody titers. Newborns may require phototherapy or exchange transfusions for jaundice.

Complications

• Severe fetal anemia or hydrops fetalis
• Preterm birth
• Neonatal jaundice requiring intensive care
• Potential for HDFN in subsequent pregnancies

Lifestyle & Prevention

• Prenatal care to detect sensitization early
• Avoiding unnecessary invasive procedures to reduce fetal-maternal blood mixing
• Rh immune globulin (if applicable, though anti-A sensitization is not Rh-related)

When to Seek Professional Help

Seek care if experiencing abdominal pain, vaginal bleeding, or reduced fetal movement. Prompt evaluation is critical if fetal distress is suspected.

Tips for Medical Coders

Document the number of fetuses (five) and trimester (second) clearly. Ensure anti-A sensitization is confirmed via laboratory testing. Code O36.1125 is specific to multifetal pregnancies with five fetuses; verify documentation supports this detail.